View Author
mutation cancer bladder analysis patient urine sample recurrence detection bladder cancer fgfr 3 mutations tumor study van der aa follow-up van der kwast urine samples sensitivity result cystoscopy assay snapshot microsatellite marker grade urothelial cell carcinoma carcinoma erasmus mc voided-urine samples bladder tumors microsatellite analysis factor receptor tumour growth primers zwarthoff surveillance urothelial urology outcome fgfr 3 mutation erasmu lurkin i codon wild-type primer kwast table trial method series value european fgfr 3 24 mo cytology fibroblast voided-urine rotterdam status steyerberg nmi-uc product smoking habits 659–668 nucleotide urine dna samples codon 249 mutation smoking bladder cancer trial visit reaction department mutation detection g 372c sense snapshot primers r 248c utility
2 Most Recent Publications
|
Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])
(Article)
Aa, M.N.M. van der Zwarthoff, E.C. Steyerberg, E.W. Boogaard, M.W. Nijsen, Y. Keur, K.A. van der Exsel, A.J.A. van Kirkels, W.J. Bangma, C.H. Kwast, Th.H. van der |
2009-03-01
|
|
A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine
(Article)
Oers, J.M.M. van Lurkin, I. Exsel, A.J.A. van Nijsen, Y. Rhijn, B.W.G. van Aa, M.N.M. van der Zwarthoff, E.C. |
2005-11-01
|